• Robert Brown has been named CFO of NxStage Medical (Lawrence, Massachusetts). Prior to joining NxStage, Brown held leadership positions in the financial group of Boston Scientific, including VP, Corporate Analysis and Control, where he and his team were responsible for the company's financial, compliance and operational audits. Brown fills the vacancy left following David Gill's announcement of his intention to resign from the position of CFO last spring. Gill had agreed to continue to work for the company until his replacement could be found. NxStage manufactures systems for the treatment of end-stage renal disease, or ESRD, and acute kidney failure.

No Comments